Selected drug complications and treatment conflicts in the presence of coexistent diseases.
The presence of different coexistent systemic diseases often times complicates the selection of the appropriate treatment of an underlying rheumatologic condition. In this article, some controversial treatment conflicts that are frequently encountered in the daily practice of rheumatology are clarified and guidelines for the best available therapeutic options are provided.
Vassilopoulos
D
D
Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Foundation, Ohio, USA.
Camisa
C
C
Strauss
R M
RM
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015897:Comorbidity; D004347:Drug Interactions; D005767:Gastrointestinal Diseases / Q000150:complications / Q000188:drug therapy; D006801:Humans; D007674:Kidney Diseases / Q000150:complications / Q000188:drug therapy; D008107:Liver Diseases / Q000150:complications / Q000188:drug therapy; D009369:Neoplasms / Q000150:complications; D017410:Practice Guidelines as Topic; D012216:Rheumatic Diseases / Q000150:complications / Q000188:drug therapy*; D012871:Skin Diseases / Q000150:complications / Q000188:drug therapy
D000894:Anti-Inflammatory Agents, Non-Steroidal; D018501:Antirheumatic Agents